Table 1: Demographic, clinical and laboratory characteristics of the study population.
Variable |
n (%) or mean ± SD |
Mean ± SD Age (years) |
58.3 ± 12.4 |
Age Categories, n (%) |
|
18-40 |
28 (8.1) |
41-54 |
100 (28.9) |
≥ 55 |
218 (63) |
Female Sex, n (%) |
209 (60.4) |
Place Of Referral, n (%) |
|
Outpatient |
305 (88.1) |
Inpatient |
41 (11.9) |
Cardiovascular Risk Factors, n (%) |
|
Diabetes |
44 (12.7) |
Smoking |
34 (9.8) |
Alcohol |
146 (42.2) |
Family History of Cardiovascular Disease |
152 (43.9) |
Anthropometric Variables |
|
Mean ± SD Height (cm) |
165.2 ± 9.2 |
Mean ± SD Weight (kg) |
75.9 ± 16.2 |
Mean ± SD BMI (kg/m2) |
27.8 ± 5.3 |
Obesity Status, n (%) |
|
Normal Weight |
127 (36.7) |
Overweight |
113 (32.7) |
Obese |
106 (30.6) |
Mean ± SD Duration of hypertension |
6.8 ± 9.1 |
Mean ± SD Systolic BP (mmhg)(mmhg) |
152 ± 23 |
Mean ± SD Diastolic BP (mmhg) |
91 ± 15 |
Hypertension Stage, n (%) |
|
Normal (Controlled) BP |
100 (28.9) |
Stage 1 |
98 (28.3) |
Stage 2 |
85 (24.6) |
Stage 3 |
63 (18.2) |
Mean ± SD Pulse Rate (beats/min) |
80 ± 15 |
Tachycardia (≥ 100b/min), n (%) |
47 (13.6) |
Laboratory Findings |
|
Mean ± SD Triglyceride (mmol/L) |
1.5 ± 0.7 |
Raised Triglyceride, n (%) |
120 (34.7) |
Mean ± SD Cholesterol (mmol/L) |
5.3 ± 3.4 |
Raised Cholesterol, n (%) |
165 (47.7) |
Mean ± SD LdL-C (mmol/L) |
3.6 ± 1.2 |
Raised LDL-C, n (%) |
202 (58.4) |
Mean ± SD HdL-C (mmol/L) |
1.1 ± 0.2 |
Low HDL-C, N (%) |
154 (44.5) |
Mean ± Hemoglobin (g/dl) |
12.6 ± 2 |
Anemia, n (%) |
110 (31.8) |
Mean ± SD eGFR (ml/min/1.73 m2) |
72.7 ± 22 |
Mean ± SD Urea Nitrogen (mmol/L) |
10.9 ± 7.7 |
Proportion With Renal Dysfunction, n (%) |
85 (24.5) |
BMI: Body Mass Index; BP: Blood Pressure; LDL: Low Density Lipoprotein; HDL: High Density Lipoprotein; eGFR: Estimated Glomerular Filtration Rate